The FDA has accepted for review Abbott Laboratories’ diagnostic test that detects an early biomarker which identifies patients at risk for acute kidney injury.
To learn more, click HERE.
Source: Abbott Laboratories
FDA to Review Abbott's Kidney Test
Posted in
News,
Abbott,
Clinical & Pharma,
Acute Kidney Injury (AKI),
Chronic Kidney Disease (CKD),
Technology,
Business,
Practice Management
Comments
- Comments
Similar Articles
Latest Articles
Subscribe
Renal Business Today
